GE HealthCare Technologies Profit Margin 2020-2023 | GEHC
Current and historical gross margin, operating margin and net profit margin for GE HealthCare Technologies (GEHC) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. GE HealthCare Technologies net profit margin as of December 31, 2023 is 8.05%.
| GE HealthCare Technologies Annual Profit Margins |
|---|
| GE HealthCare Technologies Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $37.024B | $19.552B |
| Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems (INSP) | United States | $4.855B | 0.00 |
| Axonics (AXNX) | United States | $3.435B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.072B | 0.00 |
| 10x Genomics (TXG) | United States | $3.022B | 0.00 |
| Azenta (AZTA) | United States | $3.015B | 163.85 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.918B | 0.00 |
| Enovis (ENOV) | United States | $2.779B | 20.60 |
| Hims & Hers Health (HIMS) | United States | $2.603B | 0.00 |
| Privia Health (PRVA) | United States | $2.238B | 99.26 |
| Schrodinger (SDGR) | United States | $1.679B | 0.00 |
| Omnicell (OMCL) | United States | $1.376B | 47.56 |
| Phreesia (PHR) | United States | $1.237B | 0.00 |
| Standard BioTools (LAB) | United States | $0.650B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.636B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.631B | 0.00 |
| Talkspace (TALK) | United States | $0.451B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.431B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.393B | 0.00 |
| Pulmonx (LUNG) | United States | $0.342B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.300B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.236B | 0.00 |
| Outset Medical (OM) | United States | $0.214B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.201B | 0.00 |
| American Well (AMWL) | United States | $0.150B | 0.00 |
| Augmedix (AUGX) | United States | $0.128B | 0.00 |
| TruBridge (TBRG) | United States | $0.121B | 5.17 |
| MSP Recovery (LIFW) | United States | $0.120B | 0.00 |
| 111 (YI) | China | $0.094B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.079B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.051B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.049B | 0.00 |
| Movano (MOVE) | United States | $0.039B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Syra Health (SYRA) | United States | $0.012B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| ETAO (ETAO) | United States | $0.010B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |